Your browser doesn't support javascript.
loading
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial.
Han, MeiLan K; Antila, Martti; Ficker, Joachim H; Gordeev, Ivan; Guerreros, Alfredo; Bernus, Amparo Lopez; Roquilly, Antoine; Sifuentes-Osornio, José; Tabak, Fehmi; Teijeiro, Ricardo; Bandelli, Lorraine; Bonagura, Diane S; Shu, Xu; Felser, James M; Knorr, Barbara; Cao, Weihua; Langmuir, Peter; Lehmann, Thomas; Levine, Michael; Savic, Sinisa.
Afiliación
  • Han MK; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Antila M; Department of Medicine, Clínica de Alergia Martti Antila, Sorocaba, Brazil.
  • Ficker JH; Department of Respiratory Medicine, Paracelsus Medical University, Nuernberg General Hospital, Nuremberg, Germany.
  • Gordeev I; Department of Healthcare, City Clinical Hospital n.a. O M Filatov, Moscow, Russia.
  • Guerreros A; Department of Medicine, Clínica Internacional, Lima, Peru.
  • Bernus AL; Department of Internal Medicine, University Hospital of Salamanca, University of Salamanca, CIETUS, IBSAL, Salamanca, Spain.
  • Roquilly A; Université de Nantes, CHU Nantes, EA3826 Thérapeutiques Anti-Infectieuses, Service d'Anesthésie Réanimation Chirurgicale, Hôtel Dieu, Nantes, France.
  • Sifuentes-Osornio J; Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Tabak F; Department of Infectious Disease and Clinical Microbiology, Medical School of Cerrahpasa, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Teijeiro R; Department of Medicine, Hospital General de Agudos Dr Ignacio Pirovano, CABA, Argentina.
  • Bandelli L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Bonagura DS; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Shu X; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Felser JM; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Knorr B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Cao W; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Langmuir P; Incyte Corporation, Wilmington, Delaware, USA.
  • Lehmann T; Novartis Pharma AG, Novartis Campus, Basel, Switzerland.
  • Levine M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Savic S; Department of Immunology and Allergy, Leeds Teaching Hospitals NHS Trust and National Institute for Health Research-Leeds Biomedical Research Centre, Leeds, UK.
Lancet Rheumatol ; 4(5): e351-e361, 2022 May.
Article en En | MEDLINE | ID: mdl-35368384
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido